Literature DB >> 9841871

Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades.

P Y Chan-Hui1, R Weaver.   

Abstract

The mitogen-activated protein kinase (MAPK) cascades represent one of the important signalling mechanisms in response to environmental stimuli. We report the identification of a human MAPK kinase kinase, MAPKKK4, via sequence similarity with other MAPKKKs. When truncated MAPKKK4 (DeltaMAPKKK4) was overexpressed in HEK293 cells, it was constitutively active and induced the activation of endogenous p38alpha, c-Jun N-terminal kinase (JNK)1/2 and extracellular signal-regulated kinase (ERK)2 in vivo. Kinase-inactive DeltaMAPKKK4 partly inhibited the activation of p38alpha, JNK1/2 and ERK2 induced by stress, tumour necrosis factor alpha or epidermal growth factor, suggesting that MAPKKK4 might be physiologically involved in all three MAPK cascades. Co-expressed MAP kinase kinase (MKK)-1, MKK-4, MKK-3 and MKK-6 were activated in vivo by DeltaMAPKKK4. All of the above MKKs purified from Escherichia coli were phosphorylated and activated by DeltaMAPKKK4 immunoprecipitates in vitro. When expressed by lower plasmid doses, DeltaMAPKKK4 preferentially activated MKK-3 and p38alpha in vivo. Overexpression of DeltaMAPKKK4 did not activate the NF-kappaB pathway. Immunoprecipitation of endogenous MAPKKK4 by specific antibodies showed that MAPKKK4 was activated after the treatment of K562 cells with various stress conditions. As a broadly distributed kinase, MAPKKK4 might serve as a stress responder. MAPKKK4 is 91% identical with the recently described murine MEKK-4beta and might be its human homologue. It is also identical with the recently cloned human MAP three kinase 1 except for the lack of an internal sequence homologous to the murine MEKK-4alpha isoform. Differences in the reported functional activities of the three kinases are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841871      PMCID: PMC1219910          DOI: 10.1042/bj3360599

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase.

Authors:  J L Blank; P Gerwins; E M Elliott; S Sather; G L Johnson
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

2.  Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade.

Authors:  B Stein; H Brady; M X Yang; D B Young; M S Barbosa
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

3.  Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury.

Authors:  K Z Guyton; Y Liu; M Gorospe; Q Xu; N J Holbrook
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

4.  A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases.

Authors:  P D Burbelo; D Drechsel; A Hall
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

Review 5.  The pleckstrin homology domain: an intriguing multifunctional protein module.

Authors:  G Shaw
Journal:  Bioessays       Date:  1996-01       Impact factor: 4.345

6.  Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction.

Authors:  K Yamaguchi; K Shirakabe; H Shibuya; K Irie; I Oishi; N Ueno; T Taniguchi; E Nishida; K Matsumoto
Journal:  Science       Date:  1995-12-22       Impact factor: 47.728

7.  Activation of the mitogen-activated protein kinase signaling pathway in neutrophils. Role of oxidants.

Authors:  L Fialkow; C K Chan; D Rotin; S Grinstein; G P Downey
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

8.  Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2.

Authors:  A Lin; A Minden; H Martinetto; F X Claret; C Lange-Carter; F Mercurio; G L Johnson; M Karin
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

9.  MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase.

Authors:  S Xu; D Robbins; J Frost; A Dang; C Lange-Carter; M H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  21 in total

1.  Mig-2 attenuates cisplatin-induced apoptosis of human glioma cells in vitro through AKT/JNK and AKT/p38 signaling pathways.

Authors:  Yun-wei Ou; Zi-tong Zhao; Chuan-yue Wu; Bai-nan Xu; Yong-mei Song; Qi-min Zhan
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

2.  Inhibition of pancreatic cancer cell migration by plasma anthocyanins isolated from healthy volunteers receiving an anthocyanin-rich berry juice.

Authors:  Sabine Kuntz; Clemens Kunz; Silvia Rudloff
Journal:  Eur J Nutr       Date:  2015-10-17       Impact factor: 5.614

3.  MEKK4 signaling regulates filamin expression and neuronal migration.

Authors:  Matthew R Sarkisian; Christopher M Bartley; Hongbo Chi; Fumihiko Nakamura; Kazue Hashimoto-Torii; Masaaki Torii; Richard A Flavell; Pasko Rakic
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

4.  Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway.

Authors:  Kun-Hung Shen; Shun-Hsing Hung; Li-Te Yin; Chun-Shui Huang; Chang-Hung Chao; Chein-Liang Liu; Yuan-Wei Shih
Journal:  Mol Cell Biochem       Date:  2009-08-20       Impact factor: 3.396

5.  Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells.

Authors:  Chi-Sheng Chien; Kun-Hung Shen; Jau-Shyang Huang; Shian-Chin Ko; Yuan-Wei Shih
Journal:  Mol Cell Biochem       Date:  2009-07-26       Impact factor: 3.396

6.  Antitumor effects of the flavone chalcone: inhibition of invasion and migration through the FAK/JNK signaling pathway in human gastric adenocarcinoma AGS cells.

Authors:  Su-Hsuan Lin; Yuan-Wei Shih
Journal:  Mol Cell Biochem       Date:  2014-02-09       Impact factor: 3.396

Review 7.  Role of p38 MAP Kinase Signal Transduction in Solid Tumors.

Authors:  Hari K Koul; Mantu Pal; Sweaty Koul
Journal:  Genes Cancer       Date:  2013-09

8.  Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways.

Authors:  Rhona Stein; Pankaj Gupta; Xiaochuan Chen; Thomas M Cardillo; Richard R Furman; Susan Chen; Chien-Hsing Chang; David M Goldenberg
Journal:  Blood       Date:  2010-01-25       Impact factor: 22.113

9.  Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.

Authors:  Pin-Shern Chen; Yuan-Wei Shih; Hsiang-Ching Huang; Hsing-Wen Cheng
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

10.  The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma.

Authors:  Liang Zhou; Ning Zhang; Wenjie Song; Nan You; Qingjun Li; Wei Sun; Yong Zhang; Desheng Wang; Kefeng Dou
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.